Cancer BiologyClinical EpigeneticsPeer-reviewed
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer
Janina Müller, Emre Sofyalı, Luisa E. Schwarzmüller…·Stefan Wiemann
This study identifies GLYATL1 as a mediator of endocrine resistance in luminal breast cancer by promoting metabolic and epigenetic changes that counteract estrogen deprivation.
3 citationstop 1%